Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-08-25 EW Healthcare Partners, L.P. 10% owner Sale −72,925 $11.09 $809K 3,810,835
2023-08-25 EW Healthcare Partners, L.P. 10% owner Sale −11,731 $10.45 $123K 3,799,104
2023-08-25 EW Healthcare Partners, L.P. 10% owner Sale −30,000 $10.67 $320K 3,853,760
2023-08-25 EW Healthcare Partners, L.P. 10% owner Sale −54,656 $11.19 $611K 3,799,104
2023-08-24 EW Healthcare Partners, L.P. 10% owner Sale −87,100 $11.54 $1.0M 3,935,940
2023-08-24 EW Healthcare Partners, L.P. 10% owner Sale −52,180 $10.56 $551K 3,883,760
2023-08-24 EW Healthcare Partners, L.P. 10% owner Sale −139,280 $14.62 $2.0M 3,883,760
2023-08-23 EW Healthcare Partners, L.P. 10% owner Sale −121,103 $13.05 $1.6M 4,023,040
2023-08-22 EW Healthcare Partners, L.P. 10% owner Sale −46,778 $14.62 $684K 4,144,143
2023-07-11 Zaderej Karen L. Director Option exercise +2,000 2,000
2023-07-11 Zaderej Karen L. Director Option exercise · Restricted Stock Units −2,000 4,000
2023-07-10 Duker Jay S. President and CEO Grant or award · Restricted Stock Units +50,000 50,000
2023-07-10 Duker Jay S. President and CEO Grant or award · Stock Option (Right to Buy) +100,000 100,000
2023-07-10 Lurker Nancy Executive Vice Chair Grant or award · Restricted Stock Units +33,334 33,334
2023-07-10 Lurker Nancy Executive Vice Chair Grant or award · Stock Option (Right to Buy) +66,666 66,666
2023-06-23 ADAMIS ANTHONY P Director Option exercise +2,000 2,000
2023-06-23 ADAMIS ANTHONY P Director Option exercise · Restricted Stock Units −2,000 4,000
2023-06-20 GUYER DAVID R Director Grant or award · Stock Option (Right to Buy) +26,100 26,100
2023-06-20 GUYER DAVID R Director Grant or award · Stock Option (Right to Buy) +13,000 13,000
2023-06-20 Landis John B. Director Grant or award · Stock Option (Right to Buy) +26,100 26,100

Page 22 of 31 · 616 trades